Amgen says denosumab met goals in late-stage study.
The AP (8/4) reports, "Biotechnology company Amgen Inc. said Monday its drug denosumab met the goals of a late-stage study in treating patients with cancer that has spread to their bones." For the trial, researchers "compared denosumab and" Novartis AG's "Zometa [zoledronic acid] in the treatment of bone metastases in 1,776 advanced cancer patients." Amgen reported that "the two drugs had similar effects in delaying the length of time until a patient's first bone injury and subsequent bone injuries."
The trial also showed that "the time to a subsequent event, the secondary endpoint, was also better than Zometa's, though not by a statistically significant amount," Dow Jones Newswires (8/4, Gryta) reports. Currently, "the US Food and Drug Administration is also reviewing denosumab as a treatment for osteoporosis and bone loss caused by hormone treatment in patients with breast and prostate cancer."
Reuters (8/4, Berkrot) reports that the trial is the second of three planned studies testing the drug in patients with cancer that has spread to their bones. According to Amgen, full details of the trial are expected to be presented at a future medical meeting.
Popular Posts
-
Dr. Humeira Badsha Medical center, Beach Park Plaza , Jumeira Beach Road Next to Neurospinal hospital. Phone +9714-3856009. Email info@dr...
-
Methotrexate is commonly prescribed and effectively used to treat rheumatoid arthritis and other rheumatic conditions . Methotrexate has t...
-
Yesterday I saw a lovely lady from the UK. She has been seeing her GP in the NHS system for many months with severe back pain radiating to ...
-
Articles - Peer Reviewed: 1. Badsha H, Gunes B, Grossman J, Brahn E. Troponin I assessment of cardiac involvement in patients with con...
-
Patients in Dubai still have a really hard time finding the right doctors for a variety of conditions. The right Specialists exist and usua...
-
PHILADELPHIA -- Milnacipran (Savella) improved pain and mental functioning in patients suffering from fibromyalgia, researchers said here. ...
-
I see many patients in Dubai whose fibromyalgia is not recognized or diagnosed for years. What Is Fibromyalgia? Fibromyalgia is a common con...
-
Being a Rheumatologist in the UAE is a unique experience. Most of my patients have had 3, 4 opinions for their disease, finding no solution...
-
UAE Residents Need to Get Out in the Sun More 24 May 2007 High Level of Osteopenia and Osteoporosis detected in recent screening programmes ...
No comments:
Post a Comment